We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
ATP5F1D
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • ATP5F1D
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

ATP5F1D is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 216.06
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 177.3
Number of samples 362
Samples
Sample Description pTPM
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 922.5
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 747.7
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 555.8
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 547.2
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 543.6
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 530.7
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 507.7
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 498.7
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 493.6
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 460.9
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 457.2
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 457.0
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 442.6
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 419.9
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 391.7
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 373.3
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 365.2
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 360.6
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 353.7
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 347.6
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 346.2
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 344.0
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 330.3
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 329.7
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 326.6
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 325.9
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 322.2
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 320.4
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 318.8
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 317.3
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 315.0
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 314.3
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 304.9
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 304.7
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 304.5
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 299.7
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 294.1
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 290.3
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 278.2
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 274.5
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 271.2
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 270.3
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 268.3
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 265.5
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 265.0
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 261.6
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 261.0
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 257.3
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 256.9
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 253.8
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 250.7
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 246.4
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 246.1
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 245.4
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 243.5
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 242.6
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 241.6
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 241.3
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 241.3
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 240.2
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 239.0
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 234.7
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 234.0
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 233.8
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 232.1
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 229.7
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 229.1
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 226.0
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 223.6
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 222.9
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 220.6
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 219.0
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 218.0
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 217.3
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 217.1
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 216.1
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 215.5
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 215.3
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 214.8
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 214.1
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 213.8
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 210.7
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 210.7
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 210.1
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 209.7
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 207.5
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 205.7
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 204.9
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 204.5
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 204.2
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 202.0
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 201.0
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 200.9
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 200.8
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 200.6
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 200.2
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 199.6
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 199.3
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 198.6
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 198.4
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 197.8
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 196.9
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 195.4
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 195.3
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 194.1
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 193.9
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 193.9
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 193.8
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 193.1
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 191.3
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 191.0
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 190.1
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 190.1
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 189.9
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 189.2
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 188.8
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 188.4
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 188.3
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 188.3
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 187.9
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 187.9
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 187.2
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 184.4
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 183.8
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 183.2
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 182.7
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 182.7
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 182.0
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 181.2
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 180.8
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 180.1
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 179.2
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 179.2
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 177.4
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 175.4
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 173.6
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 173.5
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 173.2
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 172.6
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 172.4
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 172.1
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 172.0
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 171.9
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 171.8
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 171.6
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 169.9
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 169.5
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 169.3
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 168.8
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 168.6
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 167.6
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 167.1
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 166.1
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 165.3
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 165.2
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 165.2
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 165.1
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 163.6
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 162.9
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 162.5
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 161.6
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 161.4
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 160.4
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 160.2
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 159.8
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 159.3
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 159.0
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 158.5
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 158.2
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 157.2
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 156.9
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 156.6
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 155.0
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 154.9
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 154.9
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 154.1
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 153.5
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 153.4
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 152.9
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 152.3
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 152.1
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 151.6
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 151.5
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 150.6
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 150.3
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 150.1
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 150.0
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 149.5
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 148.8
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 148.8
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 148.8
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 148.7
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 148.6
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 148.2
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 148.1
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 147.8
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 147.8
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 146.9
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 146.8
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 145.9
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 145.4
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 143.2
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 142.7
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 142.5
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 142.5
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 141.9
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 141.6
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 141.2
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 140.8
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 140.3
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 140.3
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 139.5
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 138.9
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 138.8
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 138.5
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 138.1
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 138.0
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 137.7
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 136.6
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 136.3
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 134.8
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 134.7
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 134.7
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 134.2
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 134.2
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 134.0
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 134.0
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 133.7
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 133.5
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 133.3
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 132.3
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 132.1
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 131.8
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 131.7
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 131.3
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 130.2
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 129.6
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 129.4
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 128.7
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 128.3
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 127.8
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 127.7
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 127.3
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 126.9
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 126.7
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 126.0
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 125.0
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 124.3
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 124.3
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 124.1
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 123.9
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 123.9
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 123.8
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 123.8
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 123.7
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 123.4
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 123.3
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 122.5
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 120.9
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 120.1
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 120.0
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 119.9
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 119.8
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 119.7
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 119.3
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 119.2
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 118.8
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 118.5
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 117.9
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 117.8
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 117.3
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 117.3
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 116.5
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 116.5
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 116.2
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 116.1
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 115.6
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 115.5
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 115.2
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 115.1
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 114.9
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 114.9
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 113.5
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 113.4
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 111.5
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 110.9
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 110.2
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 109.9
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 109.7
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 109.6
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 108.9
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 108.9
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 108.4
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 107.8
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 107.7
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 107.1
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 106.9
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 104.9
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 104.8
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 104.5
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 104.5
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 104.1
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 103.7
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 103.7
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 102.6
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 101.9
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 101.3
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 100.9
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 100.8
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 99.5
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 98.9
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 98.6
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 98.4
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 97.5
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 97.1
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 96.5
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 96.0
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 96.0
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 95.9
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 95.7
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 94.4
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 94.4
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 94.2
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 93.1
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 91.6
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 91.0
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 90.6
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 88.5
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 87.1
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 86.9
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 86.2
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 85.9
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 84.5
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 84.0
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 83.9
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 83.6
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 82.2
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 81.8
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 81.5
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 79.4
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 76.4
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 76.2
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 75.8
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 74.2
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 71.6
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 70.3
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 69.2
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 67.2
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 67.0
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 66.0
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 65.4
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 65.3
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 62.6
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 62.5
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 62.1
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 60.7
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 58.3
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 57.3
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 52.8
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 50.7
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 46.6
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 46.2
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

  Survival analysis data not available.
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
627 Tumor 2.0
571 Tumor 1.0
452 Normal 1.0
278 Normal 0.9
636 Normal 0.9
388 Normal 0.9
648 Normal 0.8
615 Tumor 0.8
227 Tumor 0.8
394 Normal 0.8
222 Normal 0.8
172 Normal 0.8
426 Normal 0.8
361 Tumor 0.8
666 Normal 0.8
314 Normal 0.8
446 Normal 0.8
436 Normal 0.8
258 Normal 0.8
366 Normal 0.8
365 Tumor 0.8
186 Normal 0.7
358 Normal 0.7
423 Tumor 0.7
162 Normal 0.7
664 Normal 0.7
465 Tumor 0.7
114 Normal 0.7
534 Normal 0.7
332 Normal 0.7
232 Normal 0.7
468 Normal 0.7
424 Normal 0.7
328 Normal 0.7
722 Normal 0.7
111 Normal 0.7
298 Normal 0.7
618 Normal 0.7
396 Normal 0.7
488 Normal 0.6
428 Normal 0.6
196 Normal 0.6
124 Normal 0.6
368 Normal 0.6
464 Normal 0.6
342 Normal 0.6
112 Tumor 0.6
392 Normal 0.6
376 Normal 0.6
662 Normal 0.6
214 Normal 0.6
564 Normal 0.6
628 Normal 0.6
414 Normal 0.6
218 Normal 0.6
432 Normal 0.6
344 Normal 0.6
698 Normal 0.6
132 Normal 0.6
713 Tumor 0.6
635 Tumor 0.6
148 Normal 0.5
456 Normal 0.5
128 Normal 0.5
443 Tumor 0.5
1043 Tumor 0.5
714 Normal 0.5
642 Normal 0.5
786 Normal 0.5
422 Normal 0.5
386 Normal 0.5
113 Tumor 0.5
912 Normal 0.5
126 Normal 0.5
462 Normal 0.5
217 Tumor 0.5
362 Normal 0.5
444 Normal 0.5
268 Normal 0.5
393 Tumor 0.5
616 Normal 0.5
354 Normal 0.5
448 Normal 0.5
257 Tumor 0.5
568 Normal 0.5
272 Normal 0.4
1032 Normal 0.4
136 Normal 0.4
138 Normal 0.4
1046 Normal 0.4
451 Tumor 0.4
188 Normal 0.4
982 Normal 0.4
672 Normal 0.4
312 Normal 0.4
1014 Normal 0.4
546 Normal 0.4
434 Normal 0.4
742 Normal 0.4
746 Normal 0.4
528 Normal 0.4
924 Normal 0.4
574 Normal 0.4
964 Normal 0.4
868 Normal 0.4
484 Normal 0.4
944 Normal 0.4
922 Normal 0.4
1026 Normal 0.4
262 Normal 0.4
958 Normal 0.4
862 Normal 0.4
938 Normal 0.4
192 Normal 0.4
723 Tumor 0.4
466 Normal 0.4
1045 Tumor 0.4
884 Normal 0.4
882 Normal 0.4
384 Normal 0.3
738 Normal 0.3
1016 Normal 0.3
914 Normal 0.3
756 Normal 0.3
513 Tumor 0.3
926 Normal 0.3
745 Tumor 0.3
967 Tumor 0.3
686 Normal 0.3
231 Tumor 0.3
433 Tumor 0.3
954 Normal 0.3
267 Tumor 0.3
286 Normal 0.3
984 Normal 0.3
864 Normal 0.3
146 Normal 0.3
427 Tumor 0.3
191 Tumor 0.3
482 Normal 0.3
356 Normal 0.3
878 Normal 0.3
515 Tumor 0.3
313 Tumor 0.3
1025 Tumor 0.3
1042 Normal 0.3
1044 Normal 0.3
352 Normal 0.3
145 Tumor 0.3
665 Tumor 0.3
911 Tumor 0.3
538 Normal 0.2
866 Normal 0.2
978 Normal 0.2
127 Tumor 0.2
925 Tumor 0.2
353 Tumor 0.2
364 Normal 0.2
537 Tumor 0.2
1027 Tumor 0.2
716 Normal 0.2
195 Tumor 0.2
228 Normal 0.2
923 Tumor 0.2
1022 Normal 0.2
518 Normal 0.2
563 Tumor 0.2
976 Normal 0.2
284 Normal 0.2
696 Normal 0.2
744 Normal 0.2
918 Normal 0.2
277 Tumor 0.2
221 Tumor 0.2
421 Tumor 0.2
968 Normal 0.2
472 Normal 0.2
952 Normal 0.2
416 Normal 0.2
818 Normal 0.2
494 Normal 0.1
981 Tumor 0.1
213 Tumor 0.1
357 Tumor 0.1
461 Tumor 0.1
467 Tumor 0.1
916 Normal 0.1
383 Tumor 0.1
641 Tumor 0.1
212 Normal 0.1
125 Tumor 0.1
412 Normal 0.1
341 Tumor 0.1
955 Tumor 0.1
728 Normal 0.1
137 Tumor 0.1
135 Tumor 0.1
297 Tumor 0.1
567 Tumor 0.1
498 Normal 0.1
956 Normal 0.1
824 Normal 0.1
463 Tumor 0.1
663 Tumor 0.1
161 Tumor 0.1
743 Tumor 0.1
858 Normal 0.1
514 Normal 0.1
966 Normal 0.1
741 Tumor 0.1
187 Tumor 0.1
413 Tumor 0.1
387 Tumor 0.1
874 Normal 0.1
516 Normal 0.1
1041 Tumor 0.1
554 Normal 0.0
171 Tumor 0.0
953 Tumor 0.0
557 Tumor 0.0
483 Tumor 0.0
411 Tumor 0.0
224 Normal 0.0
474 Normal 0.0
435 Tumor 0.0
142 Normal 0.0
367 Tumor 0.0
572 Normal 0.0
778 Normal 0.0
271 Tumor 0.0
785 Tumor 0.0
487 Tumor 0.0
863 Tumor 0.0
727 Tumor 0.0
391 Tumor 0.0
185 Tumor 0.0
697 Tumor -0.1
481 Tumor -0.1
331 Tumor -0.1
867 Tumor -0.1
695 Tumor -0.1
526 Normal -0.1
1028 Normal -0.1
527 Tumor -0.1
492 Normal -0.1
558 Normal -0.1
431 Tumor -0.1
816 Normal -0.1
1013 Tumor -0.1
395 Tumor -0.1
553 Tumor -0.1
223 Tumor -0.1
617 Tumor -0.1
915 Tumor -0.1
385 Tumor -0.1
573 Tumor -0.1
937 Tumor -0.1
375 Tumor -0.1
141 Tumor -0.1
737 Tumor -0.1
883 Tumor -0.2
536 Normal -0.2
755 Tumor -0.2
445 Tumor -0.2
873 Tumor -0.2
777 Tumor -0.2
721 Tumor -0.2
261 Tumor -0.2
147 Tumor -0.2
814 Normal -0.2
425 Tumor -0.2
524 Normal -0.2
517 Tumor -0.2
823 Tumor -0.2
671 Tumor -0.3
913 Tumor -0.3
661 Tumor -0.3
921 Tumor -0.3
123 Tumor -0.3
415 Tumor -0.3
525 Tumor -0.3
852 Normal -0.3
1031 Tumor -0.3
343 Tumor -0.3
491 Tumor -0.3
363 Tumor -0.3
523 Tumor -0.3
478 Normal -0.3
327 Tumor -0.4
533 Tumor -0.4
813 Tumor -0.4
647 Tumor -0.4
957 Tumor -0.4
535 Tumor -0.5
311 Tumor -0.5
351 Tumor -0.5
881 Tumor -0.5
447 Tumor -0.5
857 Tumor -0.5
951 Tumor -0.5
975 Tumor -0.5
851 Tumor -0.5
477 Tumor -0.5
815 Tumor -0.6
724 Normal -0.6
455 Tumor -0.6
1015 Tumor -0.6
715 Tumor -0.6
685 Tumor -0.6
977 Tumor -0.6
943 Tumor -0.7
497 Tumor -0.7
963 Tumor -0.7
877 Tumor -0.7
493 Tumor -0.7
285 Tumor -0.7
917 Tumor -0.7
471 Tumor -0.7
983 Tumor -0.7
473 Tumor -0.7
1021 Tumor -0.7
861 Tumor -0.7
355 Tumor -0.8
131 Tumor -0.8
817 Tumor -0.8
865 Tumor -0.8
211 Tumor -0.9
965 Tumor -1.0
545 Tumor -1.1
283 Tumor -1.3
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA002865
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Carcinoma, Hepatocellular, NOS
Cholangiocarcinoma

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org